BRIEF-Response Biomedical enters into agreements for going private

Thu Jun 16, 2016 3:38am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

June 16 (Reuters) - Response Biomedical Corp :

* Says deal for cash consideration of $1.12 per response share

* Entered into a definitive arrangement agreement with 1077801 B.C. Ltd, a company owned by Orbimed Asia Partners

* Says cash consideration price represents a 51% premium to closing price of response shares

* Enters into definitive agreements for going private transaction and private placement

Source text for Eikon:

Further company coverage: (Bengaluru Newsroom)